Profile: Cytoclonal Pharmaceutics Inc. is a biopharmaceutical company. We focus on the development of diagnostic and therapeutic products for the identification, treatment & prevention of cancer and infectious diseases. Our primary program concerns the development of fungal fermentation production of paclitaxel & paclitaxel treatment of polycystic kidney disease. Our research and development activities relate principally to the proprietary fungal paclitaxel production system & its diagnostic, imaging lung cancer products and human gene discovery program.